Results 51 to 60 of about 5,409,262 (407)

Associations Between Symptoms, Donor Characteristics and IgG Antibody Response in 2082 COVID-19 Convalescent Plasma Donors

open access: yesFrontiers in Immunology, 2022
Many studies already reported on the association between patient characteristics on the severity of COVID-19 disease outcome, but the relation with SARS-CoV-2 antibody levels is less clear. To investigate this in more detail, we performed a retrospective
Marieke Vinkenoog   +18 more
doaj   +1 more source

A Febrile Blood Donor [PDF]

open access: yesClinical Chemistry, 2010
A 4-day-old neonate born prematurely at 29 weeks gestation developed thrombocytopenia (platelet count 43 × 109/L) with associated severe pulmonary and intracranial hemorrhaging. Urgent transfusions with 10 mL/kg of packed red cells and 10 mL/kg of platelet concentrate were given. These were sourced from blood donated 2 days earlier in Singapore by a 21-
Tang, J.W.   +7 more
openaire   +2 more sources

Seroprevalence and risk factors on Syphilis among blood donors in Chengdu, China,from 2005 to 2017

open access: yesBMC Infectious Diseases, 2019
Background High-risk population of blood donation increases the prevalence of transmit blood-borne diseases and harm the blood safety. Syphilis accounts for approximately 10% of commonly sexually transmitted diseases.
Shuangli Liu   +9 more
doaj   +1 more source

Donor sex, age and ethnicity impact stored red blood cell antioxidant metabolism through mechanisms in part explained by glucose 6-phosphate dehydrogenase levels and activity

open access: yesHaematologica, 2020
Red blood cell (RBC) storage in the blood bank promotes the progressive accumulation of metabolic alterations that may ultimately impact the erythrocyte capacity to cope with oxidant stressors.
A. D’Alessandro   +12 more
semanticscholar   +1 more source

Advanced cell therapeutics are changing the clinical landscape: will mesenchymal stromal cells be a part of it?

open access: yesBMC Medicine, 2019
During the past 15 years there have been dramatic changes in the medical landscape, particularly in oncology and regenerative medicine. Cell therapies have played a substantial part in this progress. Cellular immunotherapies can use immune cells, such as
Richard Schäfer
doaj   +1 more source

Prognostic landscape of mitochondrial genome in myelodysplastic syndrome after stem-cell transplantation

open access: yesJournal of Hematology & Oncology, 2023
Despite mitochondrial DNA (mtDNA) mutations are common events in cancer, their global frequency and clinical impact have not been comprehensively characterized in patients with myelodysplastic neoplasia (also known as myelodysplastic syndromes, MDS ...
Jing Dong   +13 more
doaj   +1 more source

Improving Blood Donor Diversity Through Focused Recruitment Interventions [PDF]

open access: yes, 2017
Study Design: Beginning in May 2016, the Jefferson Blood Donor Center began collecting donor self-identified race/ethnicity: White, Black or African American, Hispanic, Asian or Pacific Islander, American Indian or Alaskan Native, Multiracial, Other ...
Amanullah, Sarah   +3 more
core   +1 more source

The role of HLA-DP mismatches and donor specific HLA-DP antibodies in kidney transplantation : a case series [PDF]

open access: yes, 2021
BACKGROUND: The impact of HLA-DP mismatches on renal allograft outcome is still poorly understood and is suggested to be less than that of the other HLA loci.
Abramowicz, D   +9 more
core   +2 more sources

Associations of health status with subsequent blood donor behavior—An alternative perspective on the Healthy Donor Effect from Donor InSight

open access: yesPLoS ONE, 2017
Introduction In donor health research, the ‘Healthy Donor Effect’ (HDE) often biases study results and hampers their interpretation. This refers to the fact that donors are a selected ‘healthier’ subset of a population due to both donor selection ...
K. van den Hurk   +4 more
semanticscholar   +1 more source

Potential Early Risk Biomarkers for Reduced Forced Expiratory Volume in Children Post‐Hematopoietic Cell Transplantation

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT We sought to identify potential early risk biomarkers for lung disease in children post‐allogeneic HCT. Patients with pulmonary function tests 3 months post‐transplant and plasma samples between days 7 and 14 post‐HCT were included. Six of 27 subjects enrolled had reduced forced expiratory volume 1 (FEV1) z scores.
Isabella S. Small   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy